ENTITY
Ascletis Pharma Inc

Ascletis Pharma Inc (1672 HK)

81
Analysis
Health Care • China
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
bearish•Babytree Group
•19 Nov 2018 11:47

Last Week in GER Research: Babytree, NTT, Tongcheng, IDreamSky, Fosun, Sinochem, and Mogu

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight the latest on...

Logo
733 Views
Share
bearish•Softbank Group
•12 Nov 2018 06:05

Last Week in GER Research: Softbank, Haidilao, Tongcheng-Elong, Ctrip and 360 Finance

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team.Ā Ā This week we update on Softbank Group (9984...

Logo
426 Views
Share
bearish•Softbank Group
•05 Nov 2018 06:03

Last Week in GER Research: Softbank, Babytree, Tencent Music, MYOB, Yancoal, Spotify Warning & More!

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team.Ā  Last week, Arun initiated IPO coverage...

Logo
389 Views
Share
•01 Nov 2018 14:21

Innovent Biologics (äæ”č¾¾ē”Ÿē‰©) Post IPO: Hit Our TP, What's Next?

Innovent Biologics was priced at theĀ highĀ end and itĀ started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...

Logo
821 Views
Share
•31 Oct 2018 16:39

Innovent Biologics IPO First-Day: Take Money off the Table

Despite a recentĀ spell of lacklustre early-stage biotech flotations that have slumpedĀ post-IPO, Innovent Biologics Inc (1801 HK)'s shares popped...

Logo
663 Views
Share
x